Pacemaker placement showdown: which spot protects the heart best?
NCT ID NCT07360067
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study looks at 200 adults with sick sinus syndrome who need a pacemaker. Researchers will compare two places to put the pacing wire—Bachmann's bundle or the right atrial appendage—to see which one better prevents heart damage. The goal is to learn which site leads to healthier heart structure and function over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could guide doctors to choose a better pacing site to reduce heart damage in patients with sick sinus syndrome.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who presented to Samsung Medical Center, were diagnosed with Sick Sinus Syndrome, and underwent de novo permanent pacemaker or implantable cardioverter-defibrillator implantation based on clinical indications.
- Ages
-
19 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 19 years or older * Patients diagnosed with sick sinus syndrome who are scheduled for de novo implantation of a permanent pacemaker or permanent implantable cardioverter-defibrillator * Patients or their legal representatives who voluntarily consent to the access of medical records and study data throughout the entire research period Exclusion Criteria: * Patients with persistent or permanent AF * Patients with a life expectancy of less than one year due to other comorbidities * Pregnant or breastfeeding women * Patients who refuse active treatment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sick sinus syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Samsung Medical Center
RECRUITINGSeoul, Seoul, 06351, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which pacing target keeps the heart stronger? a trial aims to find out
- Can a pacemaker slip in through the neck vein?
- Freezing or burning heart nerves: which works best for slow heartbeat?
- Tiny Pacemaker's position may change how heart beats
- New study aims to perfect heart pacing lead placement
- Taiwan launches national registry to monitor leadless pacemaker outcomes